Article
Mitochondrial SLC25A10 promotes prostate cancer progression by inhibiting ferritinophagy
20 May 2025
Abstract excerpt
Prostate cancer (PCa) is one of the most common malignancies in men worldwide and remains a major cause of cancer-related mortality. Despite advances in early diagnosis and treatment, a significant proportion of patients eventually progress to advanced or treatment-resistant disease, highlighting the urgent need for novel therapeutic targets and strategies. In this study, we systematically analyzed transcriptomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
